66K

4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[1-(pyridin-3-ylcarbonyl)piperidin-4-yl]oxy}phenyl)-3-(trifluoromethyl)benzamide

Created:	2016-02-04
Last modified:	2016-07-13

Find Related PDB Entry
1 entries where 66K is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	79
Chiral Atom Count	0
Bond Count	83
Aromatic Bond Count	18

2D diagram of 66K

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[1-(pyridin-3-ylcarbonyl)piperidin-4-yl]oxy}phenyl)-3-(trifluoromethyl)benzamide
Systematic Name (OpenEye OEToolkits)	4-[(4-methylpiperazin-1-yl)methyl]-~{N}-[4-methyl-3-(1-pyridin-3-ylcarbonylpiperidin-4-yl)oxy-phenyl]-3-(trifluoromethyl)benzamide
Formula	C₃₂ H₃₆ F₃ N₅ O₃
Molecular Weight	595.655
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1CN(C)CCN1Cc2ccc(cc2C(F)(F)F)C(Nc3ccc(C)c(c3)OC4CCN(CC4)C(=O)c5cccnc5)=O
SMILES	CACTVS	3.385	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(OC4CCN(CC4)C(=O)c5cccnc5)c3
SMILES	OpenEye OEToolkits	2.0.4	Cc1ccc(cc1OC2CCN(CC2)C(=O)c3cccnc3)NC(=O)c4ccc(c(c4)C(F)(F)F)CN5CCN(CC5)C
Canonical SMILES	CACTVS	3.385	CN1CCN(CC1)Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(OC4CCN(CC4)C(=O)c5cccnc5)c3
Canonical SMILES	OpenEye OEToolkits	2.0.4	Cc1ccc(cc1OC2CCN(CC2)C(=O)c3cccnc3)NC(=O)c4ccc(c(c4)C(F)(F)F)CN5CCN(CC5)C
InChI	InChI	1.03	InChI=1S/C32H36F3N5O3/c1-22-5-8-26(19-29(22)43-27-9-12-40(13-10-27)31(42)24-4-3-11-36-20-24)37-30(41)23-6-7-25(28(18-23)32(33,34)35)21-39-16-14-38(2)15-17-39/h3-8,11,18-20,27H,9-10,12-17,21H2,1-2H3,(H,37,41)
InChIKey	InChI	1.03	CBLZTDLZCXMNCE-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	121232411
ChEMBL	CHEMBL3963223

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.